Happi Staff11.24.20
A panel of the National Advertising Review Board (NARB), the appellate advertising law body of BBB National Programs, has recommended that Young Living Essential Oils discontinue “therapeutic grade” claims for its “essential oils,” as well as unsupported health and wellness benefit claims.
The advertising at issue, as well as other claims, had been challenged by SC Johnson & Son, Inc. before the National Advertising Division (NAD) of BBB National Programs. Following NAD’s decision in July (Case No. 6385), Young Living appealed all aspects of NAD’s findings adverse to it.
Young Living’s essential oils are considered “aromatherapy” alternative-medicine products. Among the key essential oils in Young Living’s aromatherapy products are lavender, Hinoki, Ylang-Ylang, Valerian, bergamot, davana, peppermint, rosemary, and grapefruit. Many of the Young Living products are “blends,” meaning they include two or more essential oils. Wellness benefits referred to in Young Living advertising for one or more of its aromatherapy products include:
Promoting feelings of stability and calm
Promoting restful sleep
Improving clarity, focus, or alertness
Improving mood and motivation
All of Young Living’s aromatherapy products (several hundred) are labeled “therapeutic grade.”
The NARB panel concluded that the term “therapeutic grade” is unsupported and recommended that it be discontinued.
The panel determined that the health and wellness message conveyed by the term “therapeutic grade” was not supported with the requisite scientific evidence.
The panel concluded that the term “therapeutic grade” conveys the unsupported message that Young Living’s product is rated therapeutic under an existing set of third-party standards for evaluating essential oils.
The NARB panel also determined that Young Living’s health-related product claims lack proper scientific substantiation and recommended that they be discontinued.
The panel accepted as valid the evidence showing that the chemical make-up/composition of essential oils can vary widely.
The panel noted that Young Living has no information concerning the essential oils used in the published studies it relies on for scientific support for the claimed efficacy of its own products.
The panel noted that there was no evidence in the record that blending different essential oils into one product, like Young Living does with its “blends,” does not have an impact on the claimed benefits.
Young Living stated that it will comply with NARB’s decision, but noted that the company disagreed with the legal and factual findings of the original NAD case because, according to Young Living, “NAD only relied on the summaries of the third-party studies submitted as substantiation and did not ask to have the full study reports submitted.” According to Young Living, “without reviewing the complete studies at issue, NAD should not have rejected the relevance of the results in peer-reviewed and published studies conducted by extremely well-qualified researchers from institutions such as Wesleyan University and Duke University.”
The advertising at issue, as well as other claims, had been challenged by SC Johnson & Son, Inc. before the National Advertising Division (NAD) of BBB National Programs. Following NAD’s decision in July (Case No. 6385), Young Living appealed all aspects of NAD’s findings adverse to it.
Young Living’s essential oils are considered “aromatherapy” alternative-medicine products. Among the key essential oils in Young Living’s aromatherapy products are lavender, Hinoki, Ylang-Ylang, Valerian, bergamot, davana, peppermint, rosemary, and grapefruit. Many of the Young Living products are “blends,” meaning they include two or more essential oils. Wellness benefits referred to in Young Living advertising for one or more of its aromatherapy products include:
Promoting feelings of stability and calm
Promoting restful sleep
Improving clarity, focus, or alertness
Improving mood and motivation
All of Young Living’s aromatherapy products (several hundred) are labeled “therapeutic grade.”
The NARB panel concluded that the term “therapeutic grade” is unsupported and recommended that it be discontinued.
The panel determined that the health and wellness message conveyed by the term “therapeutic grade” was not supported with the requisite scientific evidence.
The panel concluded that the term “therapeutic grade” conveys the unsupported message that Young Living’s product is rated therapeutic under an existing set of third-party standards for evaluating essential oils.
The NARB panel also determined that Young Living’s health-related product claims lack proper scientific substantiation and recommended that they be discontinued.
The panel accepted as valid the evidence showing that the chemical make-up/composition of essential oils can vary widely.
The panel noted that Young Living has no information concerning the essential oils used in the published studies it relies on for scientific support for the claimed efficacy of its own products.
The panel noted that there was no evidence in the record that blending different essential oils into one product, like Young Living does with its “blends,” does not have an impact on the claimed benefits.
Young Living stated that it will comply with NARB’s decision, but noted that the company disagreed with the legal and factual findings of the original NAD case because, according to Young Living, “NAD only relied on the summaries of the third-party studies submitted as substantiation and did not ask to have the full study reports submitted.” According to Young Living, “without reviewing the complete studies at issue, NAD should not have rejected the relevance of the results in peer-reviewed and published studies conducted by extremely well-qualified researchers from institutions such as Wesleyan University and Duke University.”